Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity
Vacuolar ATPase (V-ATPase) is regarded as a possible target in cancer treatment. It is expressed in primary acute myeloid leukemia cells (AML), but the expression varies between patients and is highest for patients with a favorable prognosis after intensive chemotherapy. We therefore investigated th...
Main Authors: | Sushma Bartaula-Brevik, Calum Leitch, Maria Hernandez-Valladares, Elise Aasebø, Frode S. Berven, Frode Selheim, Annette K. Brenner, Kristin Paulsen Rye, Marie Hagen, Håkon Reikvam, Emmet McCormack, Øystein Bruserud, Tor Henrik Anderson Tvedt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/17/5546 |
Similar Items
-
Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection
by: Hu CMJ, et al.
Published: (2018-12-01) -
F-actin reorganization by V-ATPase inhibition in prostate cancer
by: Yamhilette Licon-Munoz, et al.
Published: (2017-11-01) -
Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity
by: Ida Sofie Grønningsæter, et al.
Published: (2021-08-01) -
Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid
by: Maria Hernandez-Valladares, et al.
Published: (2021-04-01) -
The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome
by: Annette K. Brenner, et al.
Published: (2019-01-01)